S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Kimberly-Clark Pops On Successful Price Pass-Through

Tuesday, April 26, 2022 | Thomas Hughes
Kimberly-Clark Pops On Successful Price Pass-Through

Kimberly-Clark Demonstrates Resilience Of Staples Sector 

Shares of Kimberly-Clark (NYSE: KMB) popped in the wake of the Q1 earnings release for one reason and one reason alone, a successful price pass-through. The company’s margins were squeezed and earnings shrank but the successful pass-through of inflationary pressure points to continued strength for the company. The takeaway is that margins were compressed but not as much as expected and the outlook includes continued improvement in that regard as well as a boost in revenue. Trading at 24.5X the earnings estimate for 2022 the stock is highly-priced but you get a lot for what you pay including a healthy balance sheet, share repurchases, and a growing dividend

Kimberly-Clark Outperforms And Guides Higher 

Kimberly-Clark had a very solid quarter supported by strength in all units as well as higher prices. The company reported $5.1 billion in net revenue for a gain of 7.6% over last year and beat the consensus by 365 basis points. On an organic basis, sales are up 10% offsetting the impact of FX. In regards to prices, selling prices are 6% across the company with an 8% increase in personal care products. Volume and mix also helped drive top and bottom-line results rising 2% each. Sales in North America, the company’s core market, rose by 16% with double-digit gains in Baby & Child, Adult, and Feminine care products. 

Moving down to the income, gross and operating income fell double-digits on a GAAP and adjusted basis due to rising pulp costs, polymer costs, distribution, and energy costs. These were offset, however, by internal efforts to control costs as well as higher pricing to produce margins that were better than expected. On a GAAP basis, the $1.55 in EPS is down from last year’s $.172 while the adjusted $1.35 is down by 25%. The good news is that adjusted earnings beat by $0.12 or 970 basis points and allowed the company to raise its guidance. 


Kimberly-Clark execs are now expecting to see organic revenue growth of 4% to 6% compared to the previous 3% to 4% with net growth of 2% to 4%. This is an improvement but only in line with the consensus so take it with a grain of salt. The EPS outlook is similar with the $5.60 to $6.00 range bracketing the consensus but the consensus of $5.77 is closer to the low end than the top. In our view, the guidance may be cautious and additional pricing increases are expected so the odds favor outperformance and/or another increase to guidance later in the year. 

Kimberly-Clark Dividend Yield Is 3.20% 

Kimberly-Clark is a dividend grower with 49 years of increases to its credit. The payout ratio is a bit high at 80% but the cash flow is strong and earnings growth is on the table so not the red flag it could be. The yield is over 3.2%, however, and comes with a repurchase program that we see aiding upward momentum to share prices over the short, mid, and long-term. The real downside to the payout is the CAGR which isn’t high, only 4%, and it might slow further. 

The Technical Outlook: Confirms Support At Key Level 

Price action in Kimberly-Clark fell to a long-term low earlier this year but found support at that level. The price action has since popped, driven by the strong Q1 results, and confirmed the bottom of a trading range that has been in place since before the pandemic began. It is likely the price action will continue to move higher but it is also likely this highly valued stock will find resistance at the top of the range near $155. 

Kimberly-Clark Pops On Successful Price Pass-Through

Should you invest $1,000 in Kimberly-Clark right now?

Before you consider Kimberly-Clark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.

While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Kimberly-Clark (KMB)
2.5944 of 5 stars
$128.34-0.6%3.62%24.73Hold$132.93
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.